This paper examines cocaine from multiple perspectives: its historical origins in South American coca leaves and evolution into a controlled substance, the acute and chronic physiological effects of different administration routes, U.S. federal classification and sentencing guidelines for cocaine possession and distribution, and behavioral treatment modalities for cocaine addiction. The paper traces cocaine's journey from traditional use in indigenous cultures through its isolation as a pharmaceutical agent, its emergence as a recreational drug, and the legislative responses that followed. It also details how cocaine affects the brain and body depending on consumption method, and explains the primary evidence-based intervention for cocaine use disorder: contingency management and behavioral reinforcement.
Cocaine is an extremely addictive stimulant drug, but to fully understand it, we need to examine how it is produced and trace its historical development. Cocaine is extracted from the leaf of the Erythroxylon coca bush, found mostly in South America. The coca leaf, whose consumption dates back at least to 3000 BC, has long been utilized for its ability to boost energy, relieve fatigue, and lessen hunger. Historically, chewing the coca leaf was the primary mode of cocaine ingestion.
The isolation of cocaine as a pure chemical compound marked a turning point. In 1860, Albert Niemann isolated the alkaloid, and by the 1880s it was used in eye, nose, and throat surgeries as an anesthetic and to constrict blood vessels and limit bleeding. Coca leaves were also incorporated into teas and beverages, including early formulations of Coca-Cola. As cocaine's popularity increased in the 1880s and 1890s, reports of addiction emerged, and the potential harm from the drug was soon recognized.
Legislative responses followed the recognition of cocaine's dangers. The Harrison Narcotic Act of 1914 was passed to prohibit the importation of cocaine and coca leaves, with the exception of pharmaceutical uses. Widespread non-medical use of cocaine may have been delayed for decades by the introduction of pharmaceutical amphetamines in the 1930s. However, the Controlled Substances Act of 1970 strictly regulated the manufacture of pharmaceutical amphetamines, significantly reducing their availability. Around that time, the use of cocaine began increasing. This rise was further compounded by the synthesis of crack cocaine in the 1980s, which brought cocaine to the forefront of illicit drug use.
Cocaine's initial effects do not last long, but they are significant and numerous. These acute effects include euphoria, increased energy, talkativeness, and mental alertness, particularly to sensations of sight, sound, and touch. The drug can also temporarily decrease the need for food and sleep. However, the long-term effects of cocaine can be far more severe, and the specific adverse effects depend on the route of administration.
Regular intranasal use (snorting) can lead to loss of sense of smell, nosebleeds, problems with swallowing, hoarseness, and overall irritation of the nasal septum, which could result in a chronically inflamed, runny nose. Ingested cocaine can cause severe bowel gangrene due to reduced blood flow to the gastrointestinal tract. Persons who inject cocaine develop puncture marks called "tracks," most commonly on their forearms, and may experience allergic reactions to the drug itself or to additives in street cocaine, which in severe cases can result in death.
Many chronic cocaine users experience significant appetite loss and weight loss and malnourishment. Over time, the cumulative damage from repeated use affects multiple organ systems, including the cardiovascular, respiratory, and nervous systems.
"Contingency management and behavioral reinforcement for addiction recovery"
Always verify citation format against your institution’s current style guide requirements.